XML 34 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes
9 Months Ended
Mar. 29, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
Note 14. Income Taxes
The Company recorded an income tax benefit of $16.3 million and a income tax provision of $2.2 million for the three and nine months ended March 29, 2025. The Company recorded an income tax provision of $9.0 million and $25.2 million for the three and nine months ended March 30, 2024, respectively.
The income tax benefit for the three months and the income tax provision for the nine months ended March 29, 2025 primarily relates to a $25.9 million release of valuation allowance related to the acquisition of Inertial labs and income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss. The income tax provision for the three and nine months ended March 30, 2024 primarily relates to income tax in certain foreign and state jurisdictions based on the Company’s forecasted pre-tax income or loss.
The income tax provision recorded differs from the expected tax provision that would be calculated by applying the federal statutory rate to the Company’s income from continuing operations before taxes primarily due to the changes in valuation allowance for deferred tax assets attributable to the Company’s domestic and foreign income from continuing operations and the acquisition of Inertial Labs.
As of March 29, 2025 and June 29, 2024, the Company’s unrecognized tax benefits (net of Federal benefits) totaled $52.2 million and $50.7 million, respectively, and are included in deferred taxes and other non-current tax liabilities. The Company had $4.5 million accrued for the payment of interest and penalties as of March 29, 2025. The timing and resolution of income tax examinations is uncertain, and the amounts ultimately paid, if any, upon resolution of issues raised by the taxing authorities may differ from the amounts accrued for each year. Although the Company does not expect that our balance of gross unrecognized tax benefits will change materially in the next 12 months, given the uncertainty in the development of ongoing income tax examinations, the Company is unable to estimate the full range of possible adjustments to this balance.